ws016
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Feb 13, 2023 (NCT06281470)
Timeline
Indications
Studied for
Mechanism of action
- PotassiumCHELATING AGENT
Potassium chelating agent
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07251309 | Phase 3 | Dec 23, 2024 | Government of China |
| NCT06277128 | Phase 2 | Sep 11, 2023 | Government of China |
| NCT06281470 | Phase 1 | Feb 13, 2023 | Government of China |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of China | Government | 3 | 3 | 3 | 2023 |
1 organizations
Page 1 / 1